2023 annual financial data
Whitehawk Therapeutics 2023 Operating margin
Direct answer
Operating margin was -295.36%.
Operating income was -71,933,000 USD and net income was -65,765,000 USD.
Operating cash flow was -59,663,000 USD.
Get free Whitehawk Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 24,354,000 USD
- Operating income
- -71,933,000 USD
- Net income
- -65,765,000 USD
- Operating cash flow
- -59,663,000 USD